Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About George Sekulich

George Sekulich is recorded as CIO and Board Member at Emmaus Life Sciences, Inc. (EMMA). Emmaus Life Sciences, Inc. reported in an 8-K filed October 4, 2024 that George Sekulich resigned as member of the Board of Directors, effective September 30, 2024. Emmaus Life Sciences, Inc. reported in an 8-K filed October 4, 2023 that George Sekulich was appointed Director, effective October 2, 2023. Emmaus Life Sciences, Inc. reported in an 8-K filed August 23, 2023 that George Sekulich was appointed interim Co-President, effective August 21, 2023.

“On September 30, 2024, George Sekulich resigned as a member of the Board of Directors, or the Board, of Emmaus Life Sciences, Inc. ("we," "us," "our," "Emmaus" or the "company") in connection with the termination of his employment as our Chief Commercial Officer on October 4, 2024.”
Emmaus Life Sciences, Inc. Form 8-K, filed October 4, 2024 · Read the filing
“On October 2, 2023, the Board of Directors of Emmaus Life Sciences, Inc. ("we," "us," "our," "Emmaus" or the "company") appointed George Sekulich to fill a vacancy on the Board of Directors created when Yutaka Niihara, M.D., M.P.H., the former Chairman and Chief Executive Officer, resigned as a director effective September 25, 2023.”
Emmaus Life Sciences, Inc. Form 8-K, filed October 4, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Emmaus Life Sciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.